Continuous glucose monitoring in pregnant women with type 1 diabetes
- 1 November 2017
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 390 (10110) , 2329-2331
Abstract
No abstract availableFunding Information
- University of Colorado Denver
- Merck
- Novo Nordisk
- Roche
- Eli Lilly and Company
- Johnson and Johnson
- Medtronic
This publication has 12 references indexed in Scilit:
- Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trialThe Lancet, 2017
- CGM, Pregnancy, and Remote MonitoringDiabetes Technology & Therapeutics, 2017
- Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic OutcomesDiabetes Technology & Therapeutics, 2017
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal TrialDiabetes Care, 2016
- Continuous Glucose Monitoring: A Consensus Conference of the American Association of Clinical Endocrinologists and American College of EndocrinologyEndocrine Practice, 2016
- Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry ParticipantsDiabetes Care, 2013
- Reduction in Duration of Hypoglycemia by Automatic Suspension of Insulin Delivery: The In-Clinic ASPIRE StudyDiabetes Technology & Therapeutics, 2012
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Managing Preexisting Diabetes for PregnancyDiabetes Care, 2008